immunoglobulin
Intravenous Immune Globulin (IVIg) – A newly approved therapeutic option for the treatment of adult dermatomyositis
MSU Zoom Video Session Video session using ZoomLearn about Octapharma’s IVIg therapy and the results of the landmark Progress in Dermatomyositis (ProDERM) study. The successful ProDERM Study resulted in the first and only FDA-approved IVIg therapy for DM in adults. MSU and Octapharma USA are proud to co-sponsor this exciting educational program with Dr. Rohit Aggarwal.